User: Guest  Login
Title:

Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?

Document type:
Review; Journal Article; Review
Author(s):
Ren, Lei; Mota Reyes, Carmen; Friess, Helmut; Demir, Ihsan Ekin
Abstract:
BACKGROUND: Neoadjuvant therapies (neoTx) have revolutionized the treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PCa) by significantly increasing the rate of R0 resections, which remains the only curative strategy for these patients. However, there is still room for improvement of neoTx in PCa. PURPOSE: Here, we aimed to critically analyze the benefits of neoTx in LA and BR PCa and its potential use on patients with resectable PCa. We also explored the feasi...     »
Journal title abbreviation:
Langenbecks Arch Surg
Year:
2020
Journal volume:
405
Journal issue:
7
Pages contribution:
879-887
Fulltext / DOI:
doi:10.1007/s00423-020-01946-4
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/32776259
Print-ISSN:
1435-2443
TUM Institution:
Chirurgische Klinik und Poliklinik
 BibTeX